T1	Intervention 0 36	Rosiglitazone and cognitive function
T2	Intervention 494 601	clozapine-treated patients with schizophrenia were randomized to receive rosiglitazone (4mg/day) or placebo
T3	Intervention 434 461	an eight-week double-blind,
T4	Intervention 603 905	A neuropsychological battery including the Digit Span subtest from the Wechsler Adult Intelligence Scale-III (WAIS-III), the verbal fluency test, the Hopkins Verbal Learning Test (HVLT), the Trail-Making Test (TMT) and the Wisconsin Card Sorting Test (WCST) was administered at baseline and week eight.
